Organization and Summary of Significant Accounting Policies (Details Textual) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | |||||
|---|---|---|---|---|---|---|---|---|
May 31, 2019 |
Aug. 31, 2018 |
Jun. 30, 2018 |
Jun. 30, 2019 |
Jun. 30, 2018 |
Jun. 30, 2019 |
Jun. 30, 2018 |
Dec. 31, 2018 |
|
| Organization and Summary of Significant Accounting Policies (Textual) | ||||||||
| Research and development cost | $ 6,820 | $ 71,536 | $ 16,106 | $ 136,097 | ||||
| Advanced payment from sale of intellectual property | $ 100,000 | |||||||
| Contract liability | 183,889 | 99,722 | ||||||
| Deferred revenue | 278 | $ 3,167 | 278 | $ 3,167 | 278 | |||
| Additional advanced payment | $ 90,000 | |||||||
| Intangible assets estimated useful lives | 11 years | |||||||
| Preferred Stock description | In May 2019, the Company’s board of directors, pursuant to its authority to designate serial preferred stock from time to time under Article V Section B of the Company’s Articles of Incorporation (as amended to date, the “Company Articles”), adopted a resolution providing for the designation, powers, preferences, privileges, limitations, restrictions, and relative rights and terms of (i) one million five hundred thousand (1,500,000) shares of Series RX-1 Redeemable, Convertible Preferred Stock, par value $0.001 per share (the “Series RX-1 Preferred Stock”), (ii) one million (1,000,000) shares of Series RX-2 Convertible Preferred Stock, par value $0.001 per share (the “Series RX-2 Preferred Stock”) and (iii) five hundred thousand (500,000) shares of Series RX-3 Convertible Preferred Stock, par value $0.001 per share (the “Series RX-3 Preferred Stock”). The Company filed certificates of designations amending the Company Articles and reflecting the Series RX-1 Preferred Stock, Series RX-2 Preferred Stock and the Series RX-3 Preferred Stock with the Nevada Secretary of State. | |||||||
| Common stock, shares authorized | 900,000,000 | 900,000,000 | 900,000,000 | |||||
| Accrued royalties | $ 114,368 | $ 114,368 | $ 114,368 | $ 114,368 | $ 114,368 | |||
| Contract liability | $ 199,735 | 199,735 | $ 191,569 | |||||
| Customer contract, Revenue recognized | $ 15,846 | |||||||
| Series RX1 Preferred Stock [member] | ||||||||
| Organization and Summary of Significant Accounting Policies (Textual) | ||||||||
| Preferred stock, par value | $ 0.001 | $ 0.001 | ||||||
| Preferred stock, shares outstanding | 1,418,615 | 1,418,615 | ||||||
| Price per share in liquidation | $ 1.00 | $ 1.00 | ||||||
| Series RX2 Preferred Stock [member] | ||||||||
| Organization and Summary of Significant Accounting Policies (Textual) | ||||||||
| Preferred Stock description | A number equal to or greater than 1,600,000,000. | |||||||
| Common stock, shares authorized | 900,000,000 | 900,000,000 | ||||||
| Preferred stock, shares outstanding | 0 | 0 | ||||||
| Warrants to purchase | 981,316 | 981,316 | ||||||
| Series RX3 Preferred Stock [member] | ||||||||
| Organization and Summary of Significant Accounting Policies (Textual) | ||||||||
| Preferred Stock description | A number equal to or greater than 1,600,000,000. | |||||||
| Common stock, shares authorized | 900,000,000 | 900,000,000 | ||||||
| Preferred stock, shares outstanding | 0 | 0 | ||||||
| Warrants to purchase | 481,212 | 481,212 | ||||||